Bensali, Ashyana S.
HRN: 27-82-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
09/21/2025
09/28/2025
IV
23mg
Q24H
PCAP-D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes